180 related articles for article (PubMed ID: 19921960)
41. Mometasone furoate (MF) improves lung function in pediatric asthma: A double-blind, randomized controlled dose-ranging trial of MF metered-dose inhaler.
Amar NJ; Shekar T; Varnell TA; Mehta A; Philip G
Pediatr Pulmonol; 2017 Mar; 52(3):310-318. PubMed ID: 27740721
[TBL] [Abstract][Full Text] [Related]
42. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
44. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
45. Comparison of high-dose salmeterol/fluticasone and moderate-dose salmeterol/fluticasone plus low-dose mometasone in patients with severe persistent asthma.
Kurashima K; Kagiyama N; Takayanagi N; Sugita Y
Respirology; 2011 Jul; 16(5):784-9. PubMed ID: 21382132
[TBL] [Abstract][Full Text] [Related]
46. Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.
Beasley RW; Donohue JF; Mehta R; Nelson HS; Clay M; Moton A; Kim HJ; Hederer BM
BMJ Open; 2015 Feb; 5(2):e006131. PubMed ID: 25649209
[TBL] [Abstract][Full Text] [Related]
47. Inhaled mometasone furoate: A review of its use in persistent asthma in adults and adolescents.
McCormack PL; Plosker GL
Drugs; 2006; 66(8):1151-68. PubMed ID: 16789800
[TBL] [Abstract][Full Text] [Related]
48. Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma.
Skoner DP; Gentile DA; Angelini B
Allergy Asthma Proc; 2010; 31(1):10-9. PubMed ID: 20167141
[TBL] [Abstract][Full Text] [Related]
49. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
[TBL] [Abstract][Full Text] [Related]
50. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
51. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
Bateman ED; Cheung D; Lapa e Silva J; Göhring UM; Schäfer M; Engelstätter R
Pulm Pharmacol Ther; 2008; 21(3):489-98. PubMed ID: 18178494
[TBL] [Abstract][Full Text] [Related]
52. Particle size and small airway effects of mometasone furoate delivered by dry powder inhaler.
Berger R; Berger WE
Allergy Asthma Proc; 2013; 34(1):52-8. PubMed ID: 23406936
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
[TBL] [Abstract][Full Text] [Related]
54. Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function.
Rytilä P; Ghaly L; Varghese S; Chung W; Selroos O; Haahtela T;
Eur Respir J; 2008 Oct; 32(4):989-96. PubMed ID: 18508828
[TBL] [Abstract][Full Text] [Related]
55. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
Shapiro GG; Mendelson LM; Pearlman DS
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
[TBL] [Abstract][Full Text] [Related]
56. Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.
Schmier J; Leidy NK; Gower R
J Asthma; 2003 Jun; 40(4):383-93. PubMed ID: 12870834
[TBL] [Abstract][Full Text] [Related]
57. Inhaled Budesonide vis-à-vis Inhaled Mometasone in Chinese Children with Mild Persistent Asthma: A Single-Center, Retrospective Study.
Gao P; Ding Y; Yin B; Gu H
Pharmacology; 2021; 106(11-12):616-622. PubMed ID: 34518479
[TBL] [Abstract][Full Text] [Related]
58. Mometasone furoate: an effective anti-inflammatory with a well-defined safety and tolerability profile in the treatment of asthma.
Bousquet J
Int J Clin Pract; 2009 May; 63(5):806-19. PubMed ID: 19392928
[TBL] [Abstract][Full Text] [Related]
59. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[TBL] [Abstract][Full Text] [Related]
60. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
